Medindia

X

Genomics of Cardiovascular Disease: Current Clinical Applications

Friday, June 6, 2008 General News J E 4
Advertisement
KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics



WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:



Date: Thursday, June 12, 2008



Location: The George Washington University Hospital Auditorium

900 23rd Street, NW



Time: Noon - 2:50pm



Noon - 1:00pm Presentation by Dr. Kari Stefansson



Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.



The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.



1:15 - 2:50pm Luncheon panel discussion -



Moderated by Timothy McCaffrey, PhD



Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine



Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine



Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.



The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.



The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit www.cheneycardioinstitute.com.





SOURCE The Cheney Cardiovascular Institute
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Milestone Scientific Expands U.S. and Canadian Dis...
S
Sun Pharma Comments on Taro's Potential Sale of It...